Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer

被引：3

作者：

Lupo, A. ^{[1
,2
,3
,4
]}

Alifano, M. ^{[2
,5
]}

Wislez, M. ^{[1
,2
,3
,4
,6
]}

Boulle, G. ^{[1
,2
,3
]}

Velut, Y. ^{[1
,2
,3
]}

Biton, J. ^{[7
]}

Cremer, I. ^{[1
,2
,3
]}

Goldwasser, F. ^{[2
,8
]}

Leroy, K. ^{[2
,9
]}

Damotte, D. ^{[1
,2
,3
,4
]}

机构：

[1] INSERM, UMRS 1138, Equipe Canc Immune Control & Escape, Ctr Rech Cordeliers, Paris, France

[2] Univ Paris 05, F-75006 Paris, France

[3] Univ Pierre & Marie Curie Paris, F-75005 Paris, France

[4] Hop Cochin, AP HP, Serv Pathol, F-75014 Paris, France

[5] Hop Cochin, AP HP, Serv Chirurg Thorac, F-75014 Paris, France

[6] Hop Tenon, AP HP, Serv Pneumol, F-75014 Paris, France

[7] Univ Paris 13, Sorbonne Paris Cite, Lab Immunol & Immunopathol Li2P, Inserm UMR 1125,Physiopathol Cibles & Therapies P, F-93000 Bobigny, France

[8] Hop Cochin, AP HP, Serv Oncol Med, F-75014 Paris, France

[9] Hop Cochin, AP HP, Serv Genet & Biol Mol, F-75014 Paris, France

来源：

REVUE DE PNEUMOLOGIE CLINIQUE | 2018年 / 74卷 / 05期

关键词：

Lung cancer; Biomarkers; Immune checkpoint inhibitors; Immunotherapy; PULMONARY SQUAMOUS-CELL; PD-1; BLOCKADE; ANTI-PD-L1; ANTIBODY; CLINICAL-RESPONSE; CTLA-4; OPEN-LABEL; EXPRESSION; IMMUNOHISTOCHEMISTRY; MICROENVIRONMENT; MULTICENTER;

D O I：

10.1016/j.pneumo.2018.09.010

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Immune checkpoint inhibitors (ICI), targeting the PD1/PD-L1 axis has shown their efficacy in lung cancer but only in a restricted population of patients, thus it is mandatory to identify biomarkers predicting the clinical benefit. In this article we will describe and analyzed biomarkers already published, from protein, to RNA and at last DNA markers, discussing each markers feasibility and interest. In the future, combined analysis of several markers will probably be proposed, particularly with the increasing complexity of therapy schema with molecules association. (C) 2018 Elsevier Masson SAS. All rights reserved.

引用

页码：339 / 350

页数：12

共 50 条

[1] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
Tsoukalas, Nikolaos
Kiakou, Maria
Tsapakidis, Konstantinos
Tolia, Maria
Aravantinou-Fatorou, Eleni
Baxevanos, Panagiotis
Kyrgias, Georgios
Theocharis, Stamatios
JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
[2] Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer
Shien, Kazuhiko
Papadimitrakopoulou, Vassiliki A.
Wistuba, Ignacio I.
LUNG CANCER, 2016, 99 : 79 - 87
[3] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
Kerr, Keith M.
Nicolson, Marianne C.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254
[4] The Clinical Utility of PD-L1 Testing in Selecting Non-Small Cell Lung Cancer Patients for PD1/PD-L1-Directed Therapy
Villaruz, L. C.
Socinski, M. A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 212 - 214
[5] PD1 and PD-L1 Distribution Patterns in Non-Small Cell Lung Cancer: Validation of Two Novel Immunohistochemistry Markers
Chiu, Richard
Algashaamy, Khaled
Yaziji, Hadi
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1766 - 1766
[6] PD1 and PD-L1 Distribution Patterns in Non-Small Cell Lung Cancer: Validation of Two Novel Immunohistochemistry Markers
Chiu, Richard
Algashaamy, Khaled
Yaziji, Hadi
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1766 - 1766
[7] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
Shankar, Bairavi
Naidoo, Jarushka
JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
[8] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
Kumar, Rajiv
Collins, Dearbhaile
Dolly, Saoirse
McDonald, Fiona
O'Brien, Mary E. R.
Yap, Timothy A.
CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
[9] Research progression of PD-1/PD-L1 in non-small cell lung cancer
Xing Liu
Xiaodong Xie
Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
[10] PD-1 and PD-L1 Inhibitors: Activity as Single Agents and Potential Biomarkers in Non-Small Cell Lung Cancer
Goldberg, Sarah B.
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (09) : 10 - 13

← 1 2 3 4 5 →